Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (119)

2024

  1. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40

  2. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients

    Histology and histopathology, Vol. 39, Núm. 9, pp. 1133-1140

  3. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    British Journal of Surgery, Vol. 111, Núm. 1

  4. Exacerbated Activation of the NLRP3 Inflammasome in the Placentas from Women Who Developed Chronic Venous Disease during Pregnancy

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

  5. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

  6. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer

    Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865

  7. Ultrasound in the differential diagnosis of two painful nail lesions

    Piel, Vol. 39, Núm. 1, pp. 14-17

  8. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2023

  1. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  3. Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence

    Climacteric, Vol. 26, Núm. 4, pp. 388-391

  4. Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale

    Maturitas, Vol. 172, pp. 46-51

  5. Placentas from Women with Late-Onset Preeclampsia Exhibit Increased Expression of the NLRP3 Inflammasome Machinery

    Biomolecules, Vol. 13, Núm. 11

  6. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas

  7. Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA

    Climacteric, Vol. 26, Núm. 5, pp. 437-444

  8. Sequential management of postmenopausal health and osteoporosis: An update

    Maturitas, Vol. 177

  9. The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: Generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease

    Nefrologia, Vol. 43, Núm. 2, pp. 245-250

  10. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

  11. Vitiligo-like lesions induced by cyclin-dependent kinase 4 and 6 inhibitors

    Piel, Vol. 38, Núm. 8, pp. 553-556

  12. Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception

    Gynecological Endocrinology, Vol. 39, Núm. 1